These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29241911)

  • 1. A comparison of mean corpuscular volume (MCV) between thalassemia-carrier and non-thalassemia-carrier pregnant women receiving highly active antiretroviral therapy (HAART).
    Thongyou Y; Tongprasert F
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):736-739. PubMed ID: 29241911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hematological parameters in HIV-1-infected patients with and without thalassemia carriages during highly active antiretroviral therapy.
    Pornprasert S; Sonboon P; Kiatwattanacharoen S; Klinbuayaem V; Leenasirimakul P; Promping C; Inta P; Ajhan S; Leechanachai P
    HIV Clin Trials; 2009; 10(2):88-93. PubMed ID: 19487178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).
    Lertcheewakarn P; Tongprasert F
    J Med Assoc Thai; 2014 Apr; 97(4):361-8. PubMed ID: 24964676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
    Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cutoff of mean corpuscular volume (MCV) for screening of alpha-thalassemia 1 trait.
    Nunchai C; Sirichotiyakul S; Tongsong T
    J Obstet Gynaecol Res; 2020 May; 46(5):774-778. PubMed ID: 32077202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a prenatal screening procedure for beta-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV).
    Ghosh A; Woo JS; Wan CW; Machenry C; Wong V; Ma HK; Chan V; Chan TK
    Prenat Diagn; 1985; 5(1):59-65. PubMed ID: 3975223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of mean corpuscular volume testing for screening for alpha-thalassemia-1 and beta-thalassemia traits.
    Sirichotiyakul S; Maneerat J; Sa-nguansermsri T; Dhananjayanonda P; Tongsong T
    J Obstet Gynaecol Res; 2005 Jun; 31(3):198-201. PubMed ID: 15916654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs.
    Bhagat P; Kaur Sachdeva R; Sharma P; Updesh Singh Sachdeva M; Chhabra S; Sharma A; Das R
    Infect Dis (Lond); 2016 Feb; 48(2):122-6. PubMed ID: 26431373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the accuracy of the corpuscular fragility and mean corpuscular volume tests for the alpha-thalassemia 1 and beta-thalassemia traits.
    Sirichotiyakul S; Wanapirak C; Srisupundit K; Luewan S; Tongsong T
    Int J Gynaecol Obstet; 2009 Oct; 107(1):26-9. PubMed ID: 19591999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H; Wang YX; Du MX; Xu SS; Zhou BY; Li MZ
    Biomed Environ Sci; 2021 Aug; 34(8):667-671. PubMed ID: 34474730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of highly active antiretroviral therapy on obstetric conditions: A review.
    Sebitloane HM; Moodley D
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():126-131. PubMed ID: 28013100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K; Taweenan W; Fucharoen G; Fucharoen S
    Int J Lab Hematol; 2019 Aug; 41(4):513-518. PubMed ID: 31099487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY; Li Q; Song LL; Jin WJ; Ma ZH; Yu YH; Zhong M
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.